Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Anumana logo — Unlocking the Language of the Heart & Transforming Cardiac C...

Anumana

Unlocking the Language of the Heart & Transforming Cardiac Care Through Cutting-Edge AI Solutions

Founded 2021 United States Cambridge, United States 88 employees Series C Total: $117.70M AI, Health Care +1

General Information

Company Name Anumana
Founded Year 2021
Location United States Cambridge, United States +1
Founders / Decision Makers
Team member
Employees 88
Industries AI, Health Care, Medical Devices
Funding Stage Series C
Social

Get notified when Anumana moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Anumana

Anumana, founded in 2021 and headquartered in the United States, operates at the intersection of AI, Health Care, and Medical Devices. The company is dedicated to "Unlocking the Language of the Heart & Transforming Cardiac Care Through Cutting-Edge AI Solutions."

Anumana leverages advanced AI and translational science to interpret electrical signals from the heart, potentially revolutionizing patient care in the cardiac clinical pathway. With over 100+ peer-reviewed publications, Anumana shows promise in early detection and diagnosis of hidden heart conditions, propelling the concept of precision medicine.

The company secured a Series C investment on 24 April 2025, backed by prominent investors like Boston Scientific, Matrix Capital Management, Mayo Clinic Ventures, Matrix, and NTT Venture Capital. This financial support underscores confidence in Anumana's potential to set a new standard in cardiac clinical care.

Taxonomy: AI Solutions, Cardiac Care, Electrical Signals Analysis, ECG-EGM-EMR Integration, Precision Medicine, Clinical Decision Support, Machine Learning Algorithms, Cardiovascular Disease Diagnosis, Real-world Evidence Generation, Healthcare Analytics, Patient Care Transformation, Diagnostic Technology, Clinical Pathway Enhancement, Data-Driven Healthcare

Services & Products

Development and commercialization of AI solutions for cardiac care continuum

Target Customers

Healthcare institutions clinicians and patients

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 5
Investor Investor Investor Investor
•••• •••• 		24 Apr 2025
Venture Round •••••• - 17 Nov 2022
Non Equity Assistance •••••• 1
Investor
07 Jun 2022
Series B •••••• 5
Investor Investor Investor Investor
•••• •••• 		01 May 2021
Series A •••••• 4
Investor Investor Investor
•••• •••• 		14 Apr 2021

Anumana Alternatives & Competitors

View All Alternatives
Anumana vs
Carenostics
Carenostics United States

Addressing the underdiagnosis, undertreatment, and health inequities of chronic disease using AI and...

Seed
13 employees
AI, Biotechnology
Compare Anumana vs Carenostics
Anumana vs
Alana Healthcare
Alana Healthcare United States

Innovative health solutions company providing high-touch support and education for people living wit...

Debt Financing
101 employees
Health Care, Health insurance
Compare Anumana vs Alana Healthcare
Anumana vs
Polaris Healthcare
Polaris Healthcare United States

We consistently strive to connect you with the highest quality of patient care.

76 employees
Health Care
Compare Anumana vs Polaris Healthcare
View all alternatives

FAQ About Anumana

Unlocking the Language of the Heart & Transforming Cardiac Care Through Cutting-Edge AI Solutions
Anumana was founded in 2021.
Anumana is headquartered in Cambridge, United States.
Anumana operates in the following industries: AI, Health Care, Medical Devices.
Anumana has approximately 88 employees.
Anumana has completed 5 funding rounds, raising a total of $117.70M. The latest funding stage is Series C.
Anumana offers: Development and commercialization of AI solutions for cardiac care continuum.
Top alternatives and competitors to Anumana include Carenostics, Alana Healthcare, Polaris Healthcare, Health Recovery Solutions, Vital Beats. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Anumana and Carenostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Anumana and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy